Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.72B | 39.15%1.37B | 27.39%1.36B | 17.27%4.38B | -50.11%455.98M | 180.56%1.88B | -6.19%981.18M | -3.64%1.06B | 23.73%3.73B | 9.90%913.96M |
| Cost of revenue | 1.47B | 18.44%266.45M | 44.46%279.81M | 28.69%1.03B | -122.86%-63.52M | 286.76%672.27M | 32.17%224.96M | 9.77%193.69M | 83.14%798.34M | 124.21%277.86M |
| Gross profit | 5.24B | 45.31%1.1B | 23.59%1.08B | 14.17%3.35B | -18.33%519.5M | 143.28%1.2B | -13.64%756.22M | -6.19%871.29M | 13.70%2.94B | -10.12%636.1M |
| Operating expense | 8.87B | 18.96%1.77B | 41.55%1.83B | 34.98%5.48B | 13.90%1.4B | 61.89%1.3B | 45.00%1.49B | 28.89%1.29B | 59.67%4.06B | 52.37%1.23B |
| Operating profit | -3.63B | 8.23%-672.51M | -78.96%-748.59M | -89.45%-2.13B | -48.66%-876.85M | 68.59%-97.03M | -384.42%-732.83M | -483.50%-418.31M | -2,844.23%-1.12B | -508.83%-589.85M |
| Net non-operating interest income (expenses) | -352.07M | -428.88%-46.67M | -440.05%-50.6M | -251.13%-78.44M | -584.58%-49.87M | -102.89%-10.37M | -82.69%-8.82M | -83.33%-9.37M | 42.80%-22.34M | 73.24%-7.29M |
| Non-operating interest income | --6.89M | --0 | -30.77%9K | -30.56%25K | --4K | -78.26%5K | --3K | 0.00%13K | 176.92%36K | --0 |
| Non-operating interest expense | --354.28M | 428.70%46.67M | 439.40%50.61M | 255.35%77.94M | 621.19%49.35M | 102.08%10.38M | 82.75%8.83M | 83.12%9.38M | 37.12%21.93M | 64.61%6.84M |
| Total other finance cost | --4.68M | ---- | ---- | 18.78%525K | ---- | ---- | ---- | ---- | -98.08%442K | ---- |
| Net investment income | 6.07M | -0.03%-12.57M | 64.32%-1.83M | -175.53%-6.08M | -367.25%-12.57M | -249.99%-5.14M | -39.52%8.04M | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -98.27M | -26.58M | 0 | |||||||
| Income from associates and other participating interests | -390.92M | -15.47%-7.33M | -259.92%-7.6M | -839.85%-90.57M | -2,317.50%-52.9M | -31.58%-36.08M | 60.13%-6.35M | -91.78%4.75M | 238.93%12.24M | -50.79%-2.19M |
| Special income (charges) | -1.78B | -1,088.79%-1.36B | 462.56M | -877.55%-2.64B | -1,188.18%-2.51B | -2,473.04%-21.95M | -52.35%-114.07M | 0 | -270.24M | -194.52M |
| Less:Other special charges | --532.2M | --957.72M | ---698.68M | 400.52%1.04B | 373.59%921.21M | --0 | ---- | ---- | --206.84M | --194.52M |
| Less:Write off | --1.24B | --398.3M | --236.12M | 2,433.77%1.61B | --1.58B | --21.95M | --0 | --0 | --63.4M | --0 |
| Other non-operating income (expenses) | 4.97B | 695.26%683.37M | -780.59%-24.09M | -94.41%9.21M | -151.68%-83.25M | 236.19%2.98M | 4,743.86%85.93M | -14.85%3.54M | 879.84%164.82M | 1,033.80%161.08M |
| Income before tax | -1.28B | -79.10%-1.41B | 12.81%-370.15M | -303.46%-4.96B | -476.46%-3.6B | 58.95%-144.75M | -228.05%-788.71M | -3,609.24%-424.52M | -51,115.92%-1.23B | -339.94%-624.72M |
| Income tax | -2.07M | 741.06%968K | -12.33%974K | -69.70%26.02M | -98.31%1.14M | 10,235.17%23.92M | -100.83%-151K | 29.79%1.11M | 3.24%85.88M | 1,121.20%67.15M |
| Net income | -1.27B | -79.26%-1.41B | 12.81%-371.12M | -279.09%-4.99B | -420.68%-3.6B | 52.13%-168.67M | -205.01%-788.56M | -3,360.46%-425.64M | -1,436.54%-1.32B | -369.06%-691.87M |
| Net income continuous operations | ---1.27B | -79.26%-1.41B | 12.81%-371.12M | -279.09%-4.99B | -420.68%-3.6B | 52.13%-168.67M | -205.02%-788.56M | -3,360.16%-425.63M | -1,436.55%-1.32B | -369.07%-691.87M |
| Noncontrolling interests | 0 | -100K | -100K | 0 | ||||||
| Net income attributable to the company | -1.27B | -79.28%-1.41B | 12.83%-371.02M | -279.08%-4.99B | -420.66%-3.6B | 52.10%-168.77M | -204.98%-788.46M | -3,360.46%-425.64M | -1,436.54%-1.32B | -369.06%-691.87M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1.27B | -79.28%-1.41B | 12.83%-371.02M | -279.08%-4.99B | -420.66%-3.6B | 52.10%-168.77M | -204.98%-788.46M | -3,360.46%-425.64M | -1,436.54%-1.32B | -369.06%-691.87M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -36.27 | -59.66%-41.64 | 19.04%-11.44 | -271.62%-163.55 | -410.43%-117.96 | 54.37%-5.38 | -200.12%-26.08 | -3,264.29%-14.13 | -1,254.15%-44.01 | -307.58%-23.11 |
| Diluted earnings per share | -36.27 | -59.66%-41.64 | 19.04%-11.44 | -271.62%-163.55 | -410.43%-117.96 | 53.64%-5.4661 | -200.12%-26.08 | -3,264.29%-14.13 | -1,254.15%-44.01 | -307.58%-23.11 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |